Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Insight Partners seals $5.1bn exit from Dotmatics in Siemens software acquisition
Insight Partners seals $5.1bn exit from Dotmatics in Siemens software acquisition Insight Partners has agreed to sell scientific software firm Dotmatics to Siemens AG in a $5.1bn deal, marking one of the private equity firm’s largest exits to date in the enterprise...
Bridgepoint, Cinven, and TDR circle MyDentist in £800m–£900m private equity auction
Bridgepoint, Cinven, and TDR circle MyDentist in £800m–£900m private equity auction Bridgepoint, Cinven, Triton Partners, and TDR Capital are among the private equity firms bidding for MyDentist, the UK’s largest provider of NHS dental services, according to Sky News....
Blackstone, KKR, and EQT push back on UK carried interest tax reforms amid relocation risk
Blackstone, KKR, and EQT push back on UK carried interest tax reforms amid relocation risk Leading private equity firms including Blackstone, KKR, and EQT are urging the UK government to reconsider sweeping tax changes that would reclassify carried interest as income....